Page last updated: 2024-09-03

sk&f 104976 and triparanol

sk&f 104976 has been researched along with triparanol in 1 studies

*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]

*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]

Compound Research Comparison

Studies
(sk&f 104976)
Trials
(sk&f 104976)
Recent Studies (post-2010)
(sk&f 104976)
Studies
(triparanol)
Trials
(triparanol)
Recent Studies (post-2010) (triparanol)
1001410120

Protein Interaction Comparison

ProteinTaxonomysk&f 104976 (IC50)triparanol (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 27.05

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busto, R; Cano, S; Dávalos, A; de la Peña, G; Giera, M; Herrera, E; Lasunción, MA; Sánchez-Wandelmer, J1

Other Studies

1 other study(ies) available for sk&f 104976 and triparanol

ArticleYear
Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes.
    Biochimica et biophysica acta, 2009, Volume: 1788, Issue:9

    Topics: 3T3-L1 Cells; Animals; Caveolae; Caveolin 1; Cell Membrane; Cholesterol; Dehydrocholesterols; Enzyme Inhibitors; G(M1) Ganglioside; Lanosterol; Membrane Microdomains; Mice; Receptor, Insulin; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; Triparanol

2009